Cutaneous Lymphoma in Cats: Signs, Diagnosis, Treatment and Prognosis

Cutaneous Lymphoma in Cats: Signs, Diagnosis, Treatment and Prognosis

By Dr Duncan Houston

Cutaneous lymphoma can look far less serious than it really is.

A cat may begin with one bald patch, a crusted plaque, a firm lump beneath the skin or an ulcer that appears to be an allergy, infection or wound. The lesion may improve temporarily with antibiotics or steroids, only to return or appear somewhere else.

The key is recognising when a skin problem is no longer behaving like an ordinary inflammatory condition. Persistent, unusual or progressive lesions need proper tissue sampling rather than another round of treatment based on appearance alone.

Quick Answer

Cutaneous lymphoma is a rare cancer of lymphocytes that affects the skin, hair follicles, mucocutaneous tissues or tissue beneath the skin. It may appear as nodules, masses, redness, scaling, crusting, hair loss, plaques or ulcers.

Diagnosis usually requires a skin biopsy, followed by histopathology and sometimes immunohistochemistry or molecular testing. Treatment depends on whether the disease is confined to one lesion or is multifocal or systemic, and may involve surgery, radiation therapy, chemotherapy or palliative care.

What Is Cutaneous Lymphoma?

Lymphoma is a cancer of lymphocytes, which are white blood cells involved in immune function.

Cutaneous lymphoma develops when malignant lymphocytes infiltrate the skin or subcutaneous tissue. It may begin within the skin itself, which is called primary cutaneous lymphoma, or it may represent skin involvement from lymphoma that originated elsewhere in the body.

This distinction matters because a truly localised skin lesion may be treated with surgery or radiation, while secondary or disseminated disease usually requires systemic treatment. Current oncology guidance considers most feline lymphoma systemic, although rare solitary forms, including some skin lymphomas, can remain localised.

Cutaneous lymphoma is uncommon in cats. Published estimates suggest it represents approximately 0.2% to 3% of feline lymphoma diagnoses. A multicentre study of 41 cats reported a median age of 12.3 years, although younger cats can occasionally be affected.

Are All Cutaneous Lymphomas the Same?

No. Several biologically different diseases can affect the skin.

Form	Where the malignant cells are found	Typical appearance	Common cellular origin
Epitheliotropic lymphoma	Epidermis, hair follicles and other skin appendages	Red patches, scaling, plaques, crusts, ulcers, depigmentation and mucocutaneous lesions	Usually T-cell
Non-epitheliotropic lymphoma	Dermis or subcutaneous tissue without marked epidermal infiltration	Firm nodules, plaques, masses or deeper swellings	T-cell or B-cell
Subcutaneous lymphoma	Deeper fat and connective tissue beneath the skin	Painless, firm, poorly defined masses that may resemble sarcoma or inflammation	Variable
Tarsal or hock-region lymphoma	Skin or subcutaneous tissues around the hock	A firm mass, circumferential swelling, lameness or self-trauma	Often high-grade, but classification requires care
Cutaneous lymphocytosis	Indolent lymphocytic infiltration of the skin	Plaques, redness, scaling, hair loss or nodules	Usually indolent T-cell-rich or polyclonal disease

The terminology can become confusing because the lesions may look similar despite having different microscopic patterns and clinical behaviour. Histopathology and immunohistochemistry are therefore more useful than appearance alone.

What Is Epitheliotropic Cutaneous Lymphoma?

Epitheliotropic lymphoma occurs when malignant lymphocytes show a particular attraction to the epidermis, hair follicles and other epithelial structures within the skin.

It is generally a T-cell lymphoma.

Possible appearances include:

• Red or darkened patches

• Scaling

• Crusting

• Thickened plaques

• Hair loss

• Erosions

• Ulcers

• Depigmentation

• Lesions around the lips, eyelids or other mucocutaneous junctions

• Oral lesions in some cats

• Diffuse redness involving a large area of skin

Some cats are itchy, while others show little irritation despite extensive disease. Epitheliotropic lymphoma can resemble allergy, eosinophilic disease, infection or an immune-mediated skin disorder.

What Is Non-Epitheliotropic Cutaneous Lymphoma?

Non-epitheliotropic lymphoma primarily involves the dermis or subcutaneous tissues rather than concentrating within the epidermis.

The malignant cells may be T-cell or B-cell in origin.

This form commonly appears as:

• One firm nodule

• Several separate nodules

• Deep plaques

• Subcutaneous masses

• Ulcerated swellings

• Thickened or poorly movable skin

• Areas of redness and hair loss over a deeper mass

A multifocal B-cell form has been reported with numerous alopecic, red and ulcerated nodules across the trunk, abdomen, head, neck and limbs. Other cats develop a single mass that initially resembles an abscess, injection-site sarcoma or another soft-tissue tumour.

What Is Subcutaneous Lymphoma?

Subcutaneous lymphoma develops in the deeper tissues beneath the skin.

A study of 97 affected cats found that these tumours commonly appeared as painless, firm masses along the lateral chest wall, abdominal wall or interscapular region. The masses frequently invaded surrounding tissue, contained areas of central tissue death and were surrounded by inflammation.

This matters because subcutaneous lymphoma can look very similar to:

• Injection-site sarcoma

• An inflammatory granuloma

• A chronic abscess

• A foreign-body reaction

• Another round-cell tumour

Local recurrence and later disease elsewhere in the body were common in that study. A deep subcutaneous mass should therefore not be assumed to be a simple skin lump or treated with a casual marginal excision.

Why Is a Lump Near the Hock Particularly Important?

Cats can develop a distinctive group of tumours around the tarsus or hock.

Historically, many of these masses were classified as cutaneous lymphoma. More recent research shows that this region can also develop:

• Plasma cell tumours

• Feline progressive histiocytosis

• Histiocytic sarcoma

• Soft-tissue sarcoma

• Other poorly differentiated round-cell tumours

A 2026 study found that broad immunohistochemical testing changed the original diagnosis in half of the tarsal round-cell tumours examined. This means that a hock mass should not be labelled lymphoma from appearance or routine histology alone when the cellular lineage remains unclear.

Tarsal lymphoma itself can behave aggressively. In an earlier 23-cat study, systemic involvement was common and median survival was 190 days. In the 2026 series, all three cats with confirmed tarsal lymphoma already had regional lymph node involvement, and all experienced progression despite treatment. These numbers come from small retrospective groups, but they support thorough staging before relying on surgery or amputation alone.

What Is Feline Cutaneous Lymphocytosis?

Cutaneous lymphocytosis is an uncommon, usually indolent lymphoid skin disorder that can resemble low-grade lymphoma.

Cats may develop:

• Red patches

• Scaling

• Hair loss

• Plaques

• Crusting

• Ulcers

• Nodules

• Slowly progressive lesions over several years

Its exact classification remains debated. It may represent a chronic reactive process in some cats and an indolent lymphoproliferative condition in others.

This distinction is important because its clinical course is often much slower than aggressive cutaneous lymphoma. One multicentre study reported a median overall survival of 1,080 days in affected cats, and the feline infiltrates in that study were consistently T-cell-rich and polyclonal.

A pathology report describing a dense small-lymphocyte infiltrate should therefore be interpreted alongside immunohistochemistry, clonality testing, clinical progression and systemic staging rather than automatically being treated as aggressive lymphoma.

What Are the Signs of Cutaneous Lymphoma in Cats?

Cutaneous lymphoma can take several forms.

Common skin changes include:

• One or more firm nodules

• Discrete skin or subcutaneous masses

• Redness

• Hair loss

• Scaling

• Crusting

• Repeated scabbing

• Thickened plaques

• Ulceration

• Bleeding

• Depigmentation

• Moist or oozing lesions

• Poor healing

• Pain or warmth

• Itching

• Self-trauma

• Swelling around a limb or joint

In the 41-cat multicentre study, the most common examination findings included nodules, redness, crusting, scabbing, alopecia and discrete masses. Pruritus was variable but was among the more commonly reported clinical signs.

Mucocutaneous areas may be affected

Lesions can occur around:

• Lips

• Eyelids

• Nose

• Oral cavity

• Perianal tissues

• Vulva

• Prepuce

These locations can make eating, grooming, blinking, urinating or defecating uncomfortable.

Signs of deeper or systemic disease may include:

• Reduced appetite

• Weight loss

• Lethargy

• Enlarged lymph nodes

• Vomiting

• Diarrhoea

• Increased thirst

• Weakness

• Difficulty breathing

• Abdominal enlargement

• Nasal discharge

• Oral lesions

• Neurological signs

These signs do not prove that the lymphoma began elsewhere, but they increase concern that the skin disease is part of a wider systemic process.

Can Cutaneous Lymphoma Look Like an Allergy?

Yes.

Cutaneous lymphoma may initially resemble:

• Flea allergy

• Food allergy

• Environmental allergy

• Eosinophilic plaques

• Eosinophilic granuloma complex

• Bacterial skin infection

• Fungal infection

• Immune-mediated dermatitis

• An insect bite

• Chronic traumatic licking

The clinical clue is often not the appearance of the lesion but how it behaves.

A lesion becomes more suspicious when it:

• Persists despite appropriate treatment

• Returns immediately after medication is stopped

• Becomes thicker or more nodular

• Ulcerates

• Appears in several unusual locations

• Is associated with unexplained weight loss

• Produces a firm mass beneath the visible skin change

• Does not fit the expected distribution of an allergic disease

A temporary response to prednisolone does not rule lymphoma out. Lymphoma itself may shrink or become less inflamed after steroid treatment.

What Else Can Look Like Cutaneous Lymphoma?

Important differential diagnoses include:

Eosinophilic granuloma complex

Eosinophilic plaques, lip ulcers and granulomas can resemble epitheliotropic lymphoma. Cytology may identify eosinophilic inflammation, but persistent or atypical lesions may still require biopsy.

Bacterial or fungal infection

Deep bacterial infection, dermatophytosis and unusual fungal disease can cause nodules, ulcers, crusting and hair loss.

Cultures, cytology, fungal testing and biopsy may be needed.

Mast cell tumour

Feline mast cell tumours may appear as solitary or multiple skin nodules. Many cutaneous mast cell tumours are relatively benign, but cytology or biopsy is needed to distinguish them from lymphoma.

Plasma cell tumour

Plasma cell tumours can be difficult to distinguish from lymphoma, particularly around the hock. Histopathology and a broad immunohistochemical panel may be required.

Feline progressive histiocytosis

This condition causes progressive skin nodules and may eventually involve internal organs. It can be confused with cutaneous lymphoma clinically and microscopically.

Squamous cell carcinoma

Ulcerated lesions involving the nose, ears, eyelids or other poorly pigmented areas may represent squamous cell carcinoma rather than lymphoma.

Injection-site sarcoma

A firm, deep mass near a previous injection site is more commonly associated with sarcoma, but rare cutaneous lymphomas have also developed at previous injection sites.

Cutaneous lymphocytosis

This indolent lymphoid condition can closely resemble low-grade cutaneous lymphoma but often has a substantially slower course.

Abscess, granuloma or foreign body

A painful or draining nodule may be inflammatory rather than neoplastic. Failure to resolve normally should prompt biopsy.

Does Cutaneous Lymphoma Spread?

It can.

Some cats have one localised lesion for a prolonged period. Others have multiple skin lesions from the beginning or develop internal lymphoma later.

The 97-cat subcutaneous lymphoma study reported:

• Local recurrence after treatment in 43.5% of cats

• Later distant involvement in 32.2%

• Median overall survival of 148 days

These results describe a particularly aggressive subcutaneous population and should not be applied to every superficial skin lesion. They do show why staging and continued follow-up are necessary.

In the 23-cat tarsal lymphoma study, lymphoma was identified elsewhere in the body in a substantial proportion of cats during staging or follow-up.

What Causes Cutaneous Lymphoma?

The exact cause is usually unknown.

Possible contributing mechanisms include:

• Accumulated genetic changes in lymphocytes

• Abnormal immune regulation

• Chronic antigenic stimulation

• Local inflammation

• Viral influences in selected cases

• Individual susceptibility

None of these has been established as the routine cause of feline cutaneous lymphoma.

Is FeLV responsible?

A consistent association between progressive feline leukaemia virus infection and cutaneous lymphoma has not been demonstrated.

Modern studies have generally found a low prevalence of FeLV antigenaemia among affected cats. However, FeLV testing remains appropriate because infection can influence prognosis, blood-cell function, treatment and the health of other cats.

Is FIV responsible?

FIV has not been established as a direct cause of most feline cutaneous lymphomas. Testing may still be recommended as part of staging and overall health assessment.

Can injections cause cutaneous lymphoma?

Rare lymphomas have been reported at previous injection sites.

A pathological study examined 17 cats with cutaneous lymphoma arising where injections had previously been given. The lesions shared some inflammatory and anatomical features with feline injection-site sarcomas. Persistent inflammation and abnormal viral protein expression were proposed as possible contributors, but direct causation was not proven.

This rare association is not a reason to stop medically appropriate vaccination or injectable treatment.

How Worried Should You Be?

Risk level	What you may notice	What it may mean	What to do
Lower immediate risk	One small lesion that is not growing, bleeding or painful, with normal appetite and behaviour	Could be inflammatory, infectious or neoplastic	Arrange a veterinary examination within the next few days
Moderate concern	Persistent scaling, crusting, hair loss or a firm lump that has lasted more than two to four weeks	Needs cytology, testing or biopsy rather than indefinite observation	Arrange prompt investigation
High concern	Rapidly enlarging nodule, multiple lesions, ulceration, bleeding, fixation, significant itching, weight loss or enlarged lymph nodes	Greater concern for aggressive or systemic disease	Seek same-day or next-day assessment
Critical	Difficulty breathing or swallowing, collapse, severe bleeding, seizures, inability to stand or profound weakness	Possible advanced systemic disease or another emergency	Go to an emergency veterinary hospital immediately

A stable skin lesion is rarely a middle-of-the-night emergency. It is still time-sensitive when it is persistent, progressive or unusual.

How Is Cutaneous Lymphoma Diagnosed?

Diagnosis should establish:

1. Whether lymphoma is actually present

2. Which subtype is involved

3. Whether disease exists elsewhere in the body

4. Whether treatment is intended to be local or systemic

1. History and Complete Examination

Your veterinarian will ask about:

• When the lesion first appeared

• How quickly it has changed

• Previous skin disease

• Itching

• Medication response

• Vaccinations or injections at that location

• Weight loss

• Appetite

• Vomiting or diarrhoea

• Breathing changes

• FeLV and FIV status

• Previous tumours or lymphoma

The examination should include:

• Mapping every skin lesion

• Measuring nodules and masses

• Photographing affected areas

• Palpating peripheral lymph nodes

• Examining the mouth

• Checking the eyelids and mucocutaneous junctions

• Feeling the abdomen

• Assessing body weight and muscle condition

• Looking for lesions beneath the coat

A full-body examination matters because the lesion that concerns the owner may not be the only one present.

2. Fine-Needle Aspiration

Fine-needle aspiration can be useful for:

• Firm nodules

• Discrete masses

• Enlarged lymph nodes

• High-grade lymphoma

• Differentiating round-cell tumours from epithelial or mesenchymal tumours

High-grade lymphoma may exfoliate enough abnormal cells to permit a rapid cytological diagnosis.

However, a nondiagnostic aspirate does not exclude lymphoma. Flat plaques, low-grade infiltrates and heavily ulcerated lesions may release very few useful cells.

When the lesion remains suspicious, biopsy should follow rather than accepting “no abnormal cells seen” as the final answer.

3. Skin Biopsy

Histopathology is the central diagnostic test.

Depending on the lesion, the veterinarian may perform:

• Punch biopsy

• Incisional wedge biopsy

• Deep core biopsy

• Excisional biopsy of a genuinely small and localised nodule

Several biopsies may be needed when lesions differ in appearance.

Useful samples should include:

• A representative active lesion

• The edge of an ulcer rather than only dead tissue

• Sufficient depth to include the dermis and subcutaneous tissue

• A recently developed untreated lesion where possible

• Separate samples from clinically different lesions

Biopsy allows the pathologist to determine whether the malignant cells are epitheliotropic, dermal, subcutaneous, small-cell, large-cell or another round-cell tumour.

4. Immunohistochemistry

Immunohistochemistry uses antibodies to identify proteins expressed by the tumour cells.

Commonly evaluated markers may help distinguish:

• T-cell lymphoma

• B-cell lymphoma

• Plasma cell tumour

• Histiocytic disease

• Another poorly differentiated round-cell tumour

This is particularly important for tarsal masses and poorly differentiated tumours. A recent tarsal tumour study found that immunohistochemistry altered half of the preliminary diagnoses.

5. PARR and Clonality Testing

PCR for antigen receptor rearrangement, usually called PARR, examines whether the lymphocyte population contains a dominant clone.

A clonal result can support lymphoma, but it is not absolute proof of cancer.

Important limitations include:

• Some inflammatory diseases can produce clonal populations

• Some lymphomas produce negative or equivocal results

• Sample quality affects interpretation

• Cutaneous lymphocytosis may remain difficult to classify

• Histopathology and clinical behaviour still matter

PARR should be used as supporting evidence rather than a substitute for a well-collected biopsy.

6. FeLV and FIV Testing

FeLV and FIV testing is generally recommended when feline lymphoma is diagnosed or strongly suspected.

Results may affect:

• Prognosis

• Treatment planning

• Bone marrow interpretation

• Infection risk

• Management of other household cats

A negative result does not rule out lymphoma.

7. Systemic Staging

Staging may include:

• Complete blood count

• Serum biochemistry

• Urinalysis

• FeLV and FIV testing

• Thoracic radiographs

• Abdominal ultrasound

• Fine-needle aspiration of enlarged or draining lymph nodes

• Liver or spleen sampling when abnormal

• Bone marrow sampling when cytopenias or abnormal circulating cells are present

• CT or MRI for deep, fixed or anatomically complex lesions

Current oncology guidance recommends identifying tumour type, grade and stage before selecting treatment whenever these results will affect the plan.

Staging is particularly important when:

• There are multiple skin lesions

• A tarsal mass is present

• The lesion is high-grade

• Lymph nodes are enlarged

• The cat is losing weight

• Blood results are abnormal

• Systemic chemotherapy is being considered

• Local surgery or radiation is being proposed as potentially curative

Can Cutaneous Lymphoma Be Diagnosed From Appearance Alone?

No.

The same diagnosis can produce several different appearances, and several unrelated diseases can look almost identical.

A persistent crusted facial lesion might be:

• Allergy

• Eosinophilic disease

• Infection

• Squamous cell carcinoma

• Epitheliotropic lymphoma

• Cutaneous lymphocytosis

A firm hock mass might be:

• Lymphoma

• Plasma cell tumour

• Histiocytic disease

• Soft-tissue sarcoma

• Chronic inflammation

Biopsy is what turns a list of possibilities into a defensible diagnosis.

How Is Cutaneous Lymphoma Treated?

There is no single standard protocol proven to be best for every cat.

Treatment depends on:

• Solitary versus multifocal disease

• Superficial versus deep disease

• Epitheliotropic versus non-epitheliotropic pattern

• Cell size and grade

• Local lymph node involvement

• Internal disease

• Response to previous treatment

• The cat’s general health

• The treatment goal

In the largest modern cutaneous lymphoma study, 34 cats received a wide variety of treatments, including surgery, radiation, single-agent chemotherapy, combination chemotherapy and prednisolone. Twenty achieved a partial or complete response. Treatment response was associated with survival, while immunophenotype, cell size and epitheliotropism were not clearly associated with treatment response.

Surgery

Surgery may be appropriate when:

• There is one genuinely localised lesion

• Staging does not identify systemic disease

• Complete margins can be obtained

• Surgery will not create unacceptable functional impairment

• Histopathology suggests local rather than diffuse involvement

Possible procedures include:

• Excision of a solitary skin nodule

• Wide removal of involved skin and subcutaneous tissue

• Limb amputation for a localised distal-limb lesion

• More extensive surgery for a deep mass

Surgery alone is less likely to be adequate when:

• Several lesions are present

• The lesion has infiltrated a broad skin field

• Lymph nodes are involved

• The tumour is high-grade

• Internal lymphoma is present

• The lesion is one manifestation of systemic disease

The mistake is assuming that removing the visible lump has removed the whole disease.

Radiation Therapy

Radiation may be considered for:

• One localised lesion

• A lesion that cannot be removed cleanly

• Residual microscopic disease after surgery

• A painful or ulcerated mass

• A lesion in a functionally difficult location

• Palliative reduction of tumour size or discomfort

Radiation therapy can provide durable local control in appropriately selected localised tumours and can also palliate pain or dysfunction when definitive treatment is not possible.

The cat usually requires several short anaesthetic episodes for accurate positioning. The number of treatments and expected skin reaction depend on whether the protocol is definitive or palliative.

Radiation controls the treated area. It does not treat lymphoma elsewhere in the body unless a broader systemic treatment is also used.

Chemotherapy

Systemic chemotherapy is usually considered when:

• Several skin lesions are present

• Regional lymph nodes are involved

• Internal lymphoma is detected

• The tumour is high-grade

• Local treatment cannot cover all disease

• The lesion progresses after surgery or radiation

Protocols reported in cats include:

• Lomustine, also called CCNU

• COP protocols containing cyclophosphamide, vincristine and prednisolone

• CHOP-type protocols adding doxorubicin

• Other single-agent or combination protocols

• Prednisolone and chlorambucil for selected indolent small-cell disorders

Current oncology guidance lists lomustine, COP and CHOP among the systemic options used for feline lymphoma, although no protocol has been proven superior specifically for cutaneous lymphoma.

The choice should be made by an oncologist using the tumour’s grade, distribution and previous treatment.

Lomustine

Lomustine is an oral chemotherapy agent that has produced remission in individual cats with cutaneous lymphoma.

However, published feline evidence consists largely of case reports and mixed retrospective groups. It should not be presented as a reliably curative medication.

Regular blood counts and biochemical monitoring are required because bone marrow and organ toxicity can occur.

COP or CHOP chemotherapy

Multiagent protocols may be recommended for high-grade, nodal or systemic disease.

These protocols use drugs with different mechanisms to reduce the chance that resistant tumour cells survive. They require repeated veterinary visits and planned blood testing.

Cats generally tolerate veterinary chemotherapy better than many owners expect, but nausea, reduced appetite, diarrhoea and bone marrow suppression can occur. The treatment goal is to maintain quality of life rather than deliver the maximum possible drug dose.

Prednisolone

Prednisolone can temporarily reduce inflammation and shrink lymphoma.

It may be used:

• As part of chemotherapy

• To palliate signs when chemotherapy is declined

• To relieve itching or inflammation

• When a cat is too unwell for more aggressive treatment

Prednisolone alone rarely provides durable control of aggressive lymphoma.

Whenever the cat is clinically stable, biopsy should ideally be obtained before prolonged steroid treatment begins. Steroids can partially shrink the lesion and make later diagnosis more difficult.

Do not stop long-term prednisolone suddenly without veterinary instructions.

Treatment of a Solitary Lesion

A solitary lesion should not automatically be assumed to be localised.

A practical approach is:

1. Confirm the diagnosis with biopsy.

2. Stage the cat for disease elsewhere.

3. Determine whether clean local treatment is achievable.

4. Discuss surgery, radiation or both.

5. Consider systemic treatment when the lesion is high-grade or lymph nodes are involved.

6. Monitor for new skin lesions and internal progression.

Some cats with genuinely isolated disease achieve long-term control. Published evidence remains limited because most studies combine several cutaneous lymphoma subtypes and treatments.

Treatment of Multifocal or Diffuse Disease

Multifocal skin lymphoma usually requires systemic treatment.

Local surgery may still be useful for:

• One painful lesion

• A repeatedly bleeding mass

• A lesion interfering with movement

• Obtaining diagnostic tissue

However, removing individual nodules will not control malignant lymphocytes throughout the rest of the skin or body.

Chemotherapy, targeted radiation to the most problematic areas and supportive care may be combined.

Treatment of Tarsal Lymphoma

Tarsal lymphoma should be treated as potentially systemic from the beginning.

Recommended assessment commonly includes:

• Popliteal and inguinal lymph node sampling

• Chest imaging

• Abdominal ultrasound

• Sampling of suspicious internal organs

• Full histopathology

• Broad immunohistochemistry

Amputation may provide local control of a painful limb mass but does not treat lymphoma already present in lymph nodes or internal organs.

Recent feline data show that some tarsal round-cell tumours initially labelled lymphoma are actually plasma cell or histiocytic tumours. The diagnosis should therefore be secure before treatment begins.

Supportive Care

Supportive care may include:

• Pain relief

• Anti-nausea medication

• Appetite support

• Nutritional support

• Treatment of secondary infection

• Gentle wound care

• Protection from licking or scratching

• Management of diarrhoea or vomiting

• Fluid therapy

• Feeding-tube support in selected cats

• Quality-of-life assessment

Nutrition and body weight should be monitored from diagnosis through treatment. Oncology guidelines recommend treating nausea before relying on appetite stimulants and using multimodal pain management when cancer or treatment is uncomfortable.

Antibiotics may improve secondary bacterial infection but do not treat the lymphoma itself.

How Is Treatment Response Measured?

Response may be assessed through:

• Measuring lesions

• Standardised photographs

• Repeat examination

• Palpation of lymph nodes

• Repeat cytology or biopsy

• Blood testing

• Repeat ultrasound or imaging

• Body-weight trends

• Appetite and activity

• Frequency of itching, bleeding or ulceration

A complete response means that measurable disease can no longer be detected.

A partial response means that the tumour burden has decreased substantially but disease remains.

Stable disease means there has been no meaningful reduction or progression.

Progressive disease means existing lesions have grown or new lesions have appeared.

In the 41-cat study, cats that responded to treatment survived longer than those that did not. This appears more useful clinically than trying to predict the outcome from T-cell versus B-cell phenotype alone.

What Is the Prognosis?

The prognosis is highly variable.

A cat with one removable, localised lesion may have a much better outlook than a cat with multifocal high-grade lymphoma, lymph node involvement or internal disease.

Broad published outcomes include:

Disease pattern	Published outcome	Important limitation
Mixed cutaneous lymphoma populations	Survival ranging from a few months to several years	Studies combine different subtypes and treatments
Subcutaneous lymphoma	Median overall survival 148 days	Aggressive population with frequent recurrence and distant disease
Tarsal lymphoma	Median survival 190 days in one 23-cat study	Many cats developed systemic disease
Cutaneous lymphocytosis	Median survival 1,080 days	Indolent condition rather than typical aggressive lymphoma
Cats responding to treatment	Longer survival than non-responders	Exact duration depends on subtype, stage and therapy

A historical review of feline epitheliotropic lymphoma reported a median survival of approximately 10.25 months, with individual survival ranging from 2.5 months to four years. The wide range reflects how heterogeneous this disease is.

Features that may support a better outcome include:

• One localised lesion

• No internal disease

• Complete surgical removal

• Ability to use definitive radiation

• Indolent small-cell histology

• Good appetite and body condition

• Strong initial treatment response

• Ability to tolerate treatment

Features that may indicate a more guarded outlook include:

• Multiple skin lesions

• Deep subcutaneous invasion

• Tarsal high-grade disease

• Lymph node involvement

• Internal lymphoma

• Recurrence after local treatment

• Progressive weight loss

• Failure to respond to initial therapy

• Severe blood or organ abnormalities

• Inability to tolerate treatment

In the largest recent cutaneous lymphoma study, cell size, immunophenotype and epitheliotropism did not clearly predict treatment response. The study was small and heterogeneous, so these features still contribute to interpretation, but none should be used alone to give an exact survival estimate.

When Is Cutaneous Lymphoma an Emergency?

Most skin lesions are not immediate emergencies. Complications can be.

Go to an emergency veterinary hospital immediately if your cat develops:

• Open-mouth breathing

• Marked breathing effort

• Blue, grey or extremely pale gums

• Collapse

• Seizures

• Inability to stand

• Severe weakness

• Uncontrolled bleeding

• Reduced consciousness

• Rapidly expanding facial or throat swelling

• Inability to swallow

• Severe distress

Arrange same-day veterinary care if your cat has:

• A rapidly enlarging mass

• A painful, ulcerated lesion

• Repeated bleeding

• Foul discharge

• Fever or profound lethargy

• Extensive self-trauma

• Significant limb swelling or lameness

• Refused almost all food for approximately 24 hours

• Repeated vomiting or diarrhoea

• Rapid weight loss

• A chemotherapy-associated fever or marked illness

A cat receiving chemotherapy that becomes profoundly lethargic, febrile or suddenly stops eating may have significant bone marrow suppression or infection and should not wait for the next routine oncology appointment.

What Should You Do Next?

1. Photograph the lesions

Take clear photographs in consistent light.

Include a ruler beside any nodule or mass.

2. Record how the disease is changing

Document:

• Number of lesions

• Size

• Location

• Colour

• Hair loss

• Crusting

• Ulceration

• Bleeding

• Itching

• Pain

• Appetite

• Body weight

3. Arrange an examination promptly

A persistent skin lesion or unexplained mass should generally be assessed within the next few days.

Do not wait months for an unusual lesion to become obviously malignant.

4. Ask whether cytology or biopsy is more appropriate

A firm nodule may be suitable for aspiration first.

A flat, infiltrative or repeatedly treated lesion will usually require biopsy.

5. Avoid prolonged empirical steroid treatment before diagnosis

When the cat is stable enough, obtain tissue before beginning long-term prednisolone.

6. Request the exact pathology diagnosis

Useful questions include:

• Is the lesion definitely lymphoma?

• Is it epitheliotropic or non-epitheliotropic?

• Is it dermal or subcutaneous?

• Is it low-grade or high-grade?

• Is it T-cell, B-cell or unclear?

• Could it represent cutaneous lymphocytosis?

• Were immunohistochemistry or PARR performed?

• Were the surgical margins complete?

7. Complete appropriate staging

Ask whether your cat needs:

• FeLV and FIV testing

• Blood and urine tests

• Thoracic imaging

• Abdominal ultrasound

• Lymph node sampling

• Liver or spleen sampling

• CT or MRI

8. Discuss oncology or dermatology referral

Referral is particularly useful when:

• The diagnosis is unclear

• Lesions are multifocal

• A tarsal mass is present

• Surgery or radiation is being considered

• Chemotherapy is recommended

• The disease has returned

• The pathology and clinical behaviour do not agree

Referral provides additional choices. It does not commit you to aggressive treatment.

9. Decide on the treatment goal

The plan may aim to:

• Cure a local lesion

• Achieve remission

• Slow progression

• Reduce itching or pain

• Improve mobility

• Maintain appetite

• Provide comfort-focused care

The best treatment is the one that offers a realistic biological benefit without creating an unacceptable burden for the cat.

Common Mistakes Owners Should Avoid

Assuming a persistent lesion is only an allergy

Allergies are common. A progressively thickened, nodular or ulcerated lesion is not behaving like routine allergy and deserves biopsy.

Repeating antibiotics without obtaining tissue

Antibiotics may reduce secondary infection while the lymphoma continues progressing.

Assuming improvement with prednisolone excludes cancer

Lymphoma frequently responds temporarily to corticosteroids.

Relying on one nondiagnostic fine-needle aspirate

Low-grade or diffuse cutaneous lymphoma may release too few cells for diagnosis.

Removing one lump without staging

The lesion may be one part of systemic disease.

Ignoring a hock mass

Tarsal round-cell tumours can be aggressive and difficult to classify. Lymph nodes should be assessed, and immunohistochemistry may be essential.

Assuming every injection-site mass is a sarcoma

Sarcoma is important, but lymphoma, plasma cell disease and inflammatory masses can occur in similar locations.

Applying human creams or medications

Human corticosteroids, antibiotics, pain products and topical treatments may be unsafe, alter the lesion or delay diagnosis.

Focusing on lesion size while ignoring the cat

Appetite, body weight, pain, mobility and systemic signs are equally important measures of disease progression.

Can Cutaneous Lymphoma Be Prevented?

There is no proven method of preventing feline cutaneous lymphoma.

Practical measures that may support earlier detection include:

• Checking the skin during grooming

• Feeling beneath the coat for new nodules

• Examining the lips, eyelids and ear margins

• Recording body weight during senior examinations

• Investigating persistent skin lesions

• Biopsying unusual lesions before months of empirical treatment

• Testing and vaccinating against FeLV according to lifestyle risk

• Recording injection locations

• Monitoring any persistent injection-site lump

• Attending regular senior veterinary examinations

Managing allergy, infection and chronic inflammation improves skin health, but it has not been proven to prevent lymphoma.

Vaccination should not be stopped because rare lymphomas have been reported at injection sites. The infectious-disease risk and the individual cat’s vaccination needs should be discussed with a veterinarian.

How Is a Cat Monitored After Treatment?

Follow-up is individualised according to grade, stage and treatment.

It may include:

• Skin and lymph node examination

• Measurement of previous lesions

• Body-weight assessment

• Complete blood count

• Serum biochemistry

• Urinalysis

• Chest imaging

• Abdominal ultrasound

• Repeat CT or MRI

• Repeat biopsy of suspicious recurrence

Current oncology guidance commonly recommends reassessment every one to three months for high-grade tumours and every four to six months for lower-grade tumours, with adjustments based on the patient’s condition and treatment.

Contact the veterinary team earlier if:

• A new lesion appears

• A treated area begins thickening

• Ulceration returns

• Appetite falls

• Weight decreases

• Lymph nodes enlarge

• Your cat becomes lethargic

• Breathing, vomiting or stool quality changes

Not every new illness after lymphoma treatment is cancer progression. Cats can still develop ordinary infections, kidney disease, hyperthyroidism and other unrelated conditions.

Frequently Asked Questions

Is cutaneous lymphoma in cats contagious?

No. Lymphoma itself cannot spread from one cat to another. FeLV is contagious and can increase the risk of some lymphoma forms, which is why FeLV testing and risk-based vaccination remain important.

Can cutaneous lymphoma be cured?

Some genuinely localised lesions may be cured or controlled for years with complete surgery or radiation. Multifocal, high-grade or systemic disease is more commonly managed rather than permanently cured.

Is cutaneous lymphoma painful or itchy?

It can be. Ulceration, inflammation, infection and deep tissue invasion can cause pain, while epitheliotropic and inflammatory lesions may be itchy. Other cats show little obvious discomfort despite significant disease.

Can a skin biopsy cause lymphoma to spread?

There is no evidence that a properly planned skin biopsy causes lymphoma to spread. Delaying diagnosis generally creates a much greater risk than obtaining tissue.

How long can a cat live with cutaneous lymphoma?

Survival ranges from weeks to several years. Localised and indolent disease may have a much better outcome than multifocal subcutaneous or tarsal lymphoma. The cat’s response to treatment is one of the most useful prognostic indicators.

Final Takeaway

Cutaneous lymphoma in cats is rare, but it can imitate many common skin conditions.

It may appear as one firm lump, multiple nodules, redness, scaling, hair loss, crusting, ulcers or diffuse skin thickening. Some forms remain localised, while others spread to lymph nodes or internal organs.

The most important steps are:

• Biopsy persistent or unusual lesions

• Determine the exact histological form

• Use immunohistochemistry when cell lineage is unclear

• Stage the cat for disease elsewhere

• Match treatment to whether the disease is localised or systemic

• Monitor appetite, weight, comfort and quality of life alongside the skin

The mistake is not failing to identify lymphoma from appearance alone. Even experienced clinicians cannot reliably do that. The mistake is allowing an unusual lesion to receive repeated empirical treatment without eventually obtaining tissue.

---

If you are unsure whether your cat’s skin lump, ulcer, biopsy result or treatment response requires urgent attention, ASK A VET™ can help you organise the findings and prepare the right questions for your veterinarian.